10
G. Valarmathy et al. / Journal of Molecular Structure 1199 (2020) 127029
potential midway between the peak potentials is formal reduction
potential (E1/2)(Table 2). The ratio of anodic and cathodic current
for all the complexes (ipa/ipc<1) confirms the quasireversible pro-
cess [27]. From the peak separation value and peak potentials, the
electrode process is found to be consistent with the
quasiereversibility of the M(II)/M(I) and M(I)/M(II) couple.
1
1
1
ꢁ
ꢂ ¼ ꢁ
ꢂ þ
ꢁ
ꢂ
F0 ꢁ F
F0 ꢁ F0
0
K F ꢁ F ½Qꢃ
0
where K is the binding constant, F is the initial fluorescence in-
tensity of the complex, F is the fluorescence intensity of alizarin red
0
S adsorbed Cu(II)complex and F is the observed fluorescence in-
0
3.9. In-vitro biological activities of the complexes
tensity at its maximum. The plot of 1/(F eF) versus 1/[Q] gives a
straight line (inset Fig. 12) and from the slope, the calculated
4
ꢁ1
0
Antibacterial and antifungal activity of Schiff base and its com-
plexes (Table 3) have been tested by disc diffusion technique
28,29]. The various gram positive and gram-negative bacterial
binding constant (K
b
) are found to be 2.22 ꢂ 10 M . There is a
good linear relationship [R ¼ 0.996] between 1/(F eF) and the
reciprocal concentration of alizarin red S. The overlap between
emission spectrum of donor Cu(II) complex and absorption spec-
trum of the acceptor (alizarin red S) indicates the energy transfer.
Since there is no wavelength overlap between absorption of
acceptor (alizarin red S) and emission of donor (complex), energy
transfer between donor and acceptor is negligible. The thermody-
namic feasibility of the excited state electron transfer reactions was
calculated by employing the well-known Rehm-Weller expression
[33].
[
organisms such as gram-negative bacteria (Staphylococcus aureus)
and fungi (candida albicans) are used to find out the antimicrobial
assay. The results were compared with standard drug Ciprofloxa-
cin ¼ 5mg/disc and Nystatin ¼ 100 mg/disc for fungi. All the new
complexes showed a remarkable biological activity against bacteria
and fungus as indicated in Figs. 8 and 9. Thus the complexes were
observed to be more active against Staphylococcus aureus and
candida albicans. The enhancement in antimicrobial activity of the
metal complexes as compared to Schiff base may be explained on
the basis of Tweedy's chelation theory [30].
ðoxÞ
:ðredÞ
1=2
D
Get ¼ E1 ꢁ E
ꢁ Es þ C
=2
3
.10. Invitro cell growth inhibition assay of [Cu(L)
2
Cl
2
] complex
*
E
¼ Es=sþ ꢁ Es;
s=sþ
The metal complexes may also be a vehicle for activation of the
The higher negative
electron transfer process is thermodynamically favourable. The
excited state oxidation potentials E* of the Cu(II)complex
D
Get values (ꢁ3.57 eV) indicate that the
ligand as the cytotoxic agent. The in vitro cytotoxicity of the newly-
synthesised complexes with remarkable antimicrobial activity
were carried out in human tumor cell lines. Cell line namely human
breast cancer cell line (MCF-7) were assayed by the.
s/sþ
is ꢁ2.9 V the oxidation potential of complexes is E
s/sþ
is 0.49 V and
the excited state energy of the Cu(II) complex is 3.4eV. The transfer
of electron from excited state of the complex to CB of dye is ener-
getically favourable [34,35]. (Fig. 13).
3
-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide
MTT) assay [31]. The complexes were initially dissolved in neat
dimethyl sulfoxide (DMSO) to make a stock solution and additional
five series of dilutions (6.25 M, 12.5 M, 25 M, 50 M, 100 M)
were made to provide a total of five sample concentrations. The
concentration of the compounds at % cell inhibition growth (IC50
(
m
m
m
m
m
4. Conclusions
)
was calculated. The percentage cell inhibition was determined us-
ing the following formula.
In this work the synthesis of Co(II), Ni(II) and Cu(II) complexes of
the Schiff base 4-((2-hydroxybenzylidene)amino)-N-(1,3-thiazol-2-
yl)benzenesulfonamide has been described. The low molar
conductance values indicate the absence of anion outside the
sphere. From the spectral data, the structure of the complexes
corresponds to a six coordinate, the binding set includes phenolic
oxygen and imine nitrogen of the ligand to the metal (II) centre. The
absence of water molecules has been confirmed by thermal anal-
ysis. The metal ligand stoichiometry in all the complexes is 1:2.
Based on these facts, an octahedral structure has been proposed for
all complexes. The process of chelation affects the biological ac-
tivity of the complexes that are potent against pathogens. It is
observed that the potency to act against the cancerous cell is highly
influenced by the nature of the metal ion present in the chelate. The
feasibility of the reaction has been established from fluorescence
quenching studies. The fluorophore Cu(II) complex is effectively
quenched by alizarin in DMSO.
%
Cell Inhibition ¼ 100 ꢁ Abs ðsampleÞ = Abs ðcontrolÞ ꢂ 100
Cytotoxicity activity of [Cu(L) Cl ] complex is shown in Fig. 10.
2
2
The Cu(II) complex derived from 4-((2-hydroxybenzylidene)
amino-N-(1,3-thiazol-2-yl) benzenesulfonamide (L) shows excel-
lent cytotoxicity towards human breast cancer cell (MCF -7). The
complex exhibit considerable IC50 value 56.15 g/ml. The concen-
m
tration of the complex at 50% cell growth was inhibited and IC50
was calculated is shown in Table 4. The regression graph between %
cell inhibition and log concentration and shown in Fig.11. Nonlinear
regression graph was plotted between % cell inhibition and log
concentration and IC50 was determined using GraphPad Prism
software. The better cytotoxicity activity of Cu (II) complex against
(
MCF -7) may play a significant role in metallodrug formulation.
3.11. Fluorescence quenching studies of [Cu(L)
2 2
Cl ]
The excited state interaction of [Cu(L) Cl ] complex with alizarin
2
2
%
Cell Inhibition
red S dye was carried out through fluorescence measurements.
Fig. 12 show the emission spectrum of Cu(II) complex measured in
DMSO. It was observed that the Cu(II) complex were effectively
quenched by increasing the concentration of alizarin red S dye
0
2
2
50
100
.25
.5
5
0.08
1.53
16.69
34.27
98.38
IC 50
R2
56.15
mM
0.9636
ꢁ
5
(
0e5 ꢂ 10 M). The binding constant for this type of interaction
was calculated using fluorescence quenching data by from the
The % cell inhibition was determined using the following formula.
formula [32].
% Cell Inhibition ¼ 100- Abs (sample)/Abs (control) ꢂ100.